Louisiana State Employees Retirement System Invests $1.53 Million in Innospec Inc. (NASDAQ:IOSP)

Louisiana State Employees Retirement System purchased a new position in Innospec Inc. (NASDAQ:IOSP - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 12,400 shares of the specialty chemicals company's stock, valued at approximately $1,528,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the business. Vanguard Group Inc. lifted its stake in Innospec by 0.4% during the third quarter. Vanguard Group Inc. now owns 2,941,356 shares of the specialty chemicals company's stock valued at $300,607,000 after purchasing an additional 11,502 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in Innospec by 1.0% during the first quarter. Dimensional Fund Advisors LP now owns 1,168,986 shares of the specialty chemicals company's stock valued at $108,190,000 after purchasing an additional 11,943 shares during the last quarter. Victory Capital Management Inc. lifted its stake in Innospec by 5.0% during the fourth quarter. Victory Capital Management Inc. now owns 1,022,850 shares of the specialty chemicals company's stock valued at $105,210,000 after purchasing an additional 49,098 shares during the last quarter. State Street Corp lifted its stake in Innospec by 1.9% during the second quarter. State Street Corp now owns 911,808 shares of the specialty chemicals company's stock valued at $87,342,000 after purchasing an additional 16,835 shares during the last quarter. Finally, Wasatch Advisors Inc. lifted its stake in Innospec by 7.4% during the first quarter. Wasatch Advisors Inc. now owns 689,527 shares of the specialty chemicals company's stock valued at $63,816,000 after purchasing an additional 47,327 shares during the last quarter. 96.64% of the stock is owned by institutional investors and hedge funds.


Innospec Trading Up 1.2 %

IOSP stock traded up $1.46 on Friday, hitting $122.28. 67,137 shares of the company's stock traded hands, compared to its average volume of 69,688. The stock has a market cap of $3.05 billion, a price-to-earnings ratio of 21.95 and a beta of 1.10. Innospec Inc. has a 1-year low of $91.74 and a 1-year high of $131.18. The stock has a fifty day moving average of $124.29 and a 200-day moving average of $115.40.

Innospec (NASDAQ:IOSP - Get Free Report) last issued its quarterly earnings results on Tuesday, February 13th. The specialty chemicals company reported $1.84 EPS for the quarter, beating the consensus estimate of $1.59 by $0.25. The business had revenue of $494.70 million during the quarter, compared to the consensus estimate of $479.47 million. Innospec had a net margin of 7.14% and a return on equity of 13.69%. The firm's quarterly revenue was down 3.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.20 EPS. On average, equities research analysts anticipate that Innospec Inc. will post 6.77 earnings per share for the current fiscal year.

Insider Buying and Selling at Innospec

In other news, VP Philip John Boon sold 3,715 shares of the stock in a transaction on Thursday, February 22nd. The shares were sold at an average price of $122.07, for a total transaction of $453,490.05. Following the transaction, the vice president now owns 18,516 shares in the company, valued at approximately $2,260,248.12. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, CEO Patrick Williams sold 9,667 shares of the firm's stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $124.37, for a total value of $1,202,284.79. Following the transaction, the chief executive officer now directly owns 174,334 shares in the company, valued at approximately $21,681,919.58. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP Philip John Boon sold 3,715 shares of the firm's stock in a transaction on Thursday, February 22nd. The shares were sold at an average price of $122.07, for a total transaction of $453,490.05. Following the completion of the transaction, the vice president now owns 18,516 shares in the company, valued at $2,260,248.12. The disclosure for this sale can be found here. In the last quarter, insiders have sold 36,500 shares of company stock worth $4,532,959. 1.52% of the stock is currently owned by company insiders.

About Innospec

(Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

See Also

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

→ Gold Mania (From Stansberry Research) (Ad)

Should you invest $1,000 in Innospec right now?

Before you consider Innospec, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list.

While Innospec currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Featured Articles and Offers

Search Headlines: